Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-21-000721
Filing Date
2021-02-01
Accepted
2021-02-01 11:40:24
Documents
9
Period of Report
2021-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5754
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5107
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 6864
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 4606
5 GRAPHIC exhibit99-2xu001.jpg GRAPHIC 9588
6 GRAPHIC exhibit99-2xu002.jpg GRAPHIC 6315
7 GRAPHIC exhibit99-2xu003.jpg GRAPHIC 3113
8 GRAPHIC exhibit99-3xu001.jpg GRAPHIC 5959
9 GRAPHIC exhibit99-3xu002.jpg GRAPHIC 5020
  Complete submission text file 0001062993-21-000721.txt   65658
Mailing Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9
Business Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 21575499
SIC: 2833 Medicinal Chemicals & Botanical Products